Welcome and General Session 4: The Evolving Landscape of Neuroendocrine Tumors
Jennifer A. Chan, MD, MPH—Chair, Dana-Farber Cancer Institute
Parag Parikh, MD—Chair, Henry Ford Cancer Institute
Shishir K. Maithel, MD, FACS
Winship Cancer Institute, Emory University
Welcome of the Day
Arvind Dasari, MD, MS
The University of Texas MD Anderson Cancer Center
Classification and Evaluation of NETs to Guide Management Strategies
James R. Howe, MD
University of Iowa Carver College of Medicine
Surgical Management of Neuroendocrine Tumors
Summary:
Optimal Surgical Approach to NETs
- Remove the primary
- Resect regional nodes
- Cholecystectomy
- Cytoreduce liver metastases
- Use Somatostatin analogues
- Use systemic therapy when other options not feasible or at progression
Erik Mittra, MD, PhD
Oregon Health and Science University
PRRT: Sequencing and Navigating the Treatment Armamentarium
Jennifer A. Chan, MD, MPH
Dana-Farber Cancer Institute
Current and Upcoming Clinical Trials
Erik Mittra, MD, PhD
Oregon Health and Science University
PRRT: Sequencing and Navigating the Treatment Armamentarium
Jennifer A. Chan, MD, MPH
Dana-Farber Cancer Institute
Current and Upcoming Clinical Trials